CannaPharmaRx, Inc. (CPMD) stock
CPMDOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 16, 2026Market cap $2.54MP/E –Yield –
CannaPharmaRx shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
CannaPharmaRx's shares outstanding was 1.27B at Sep 30, 2026. For fiscal 2025 it was 663M, up 6.0% from the year before. Over ten years it grew 45.7% a year on average. The highest annual figure on record is 663M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 663M | +6.0% |
| FY2024 | Dec 31, 2024 | 625M | +102.4% |
| FY2023 | Dec 31, 2023 | 309M | +46.4% |
| FY2022 | Dec 31, 2022 | 211M | +182.6% |
| FY2021 | Dec 31, 2021 | 75M | +83.5% |
| FY2020 | Dec 31, 2020 | 41M | +30.6% |
| FY2019 | Dec 31, 2019 | 31M | +73.5% |
| FY2018 | Dec 31, 2018 | 18M | +0.0% |
| FY2017 | Dec 31, 2017 | 18M | 0.0% |
| FY2016 | Dec 31, 2016 | 18M | +17.1% |
| FY2015 | Dec 31, 2015 | 15M | +38.6% |
| FY2014 | Dec 31, 2014 | 11M | +364.2% |
| FY2013 | Dec 31, 2013 | 2M | 0.0% |
| FY2012 | Dec 31, 2012 | 2M | 0.0% |
| FY2011 | Dec 31, 2011 | 2M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 1.27B | +91.7% |
| Q2 FY2026 | Jun 30, 2026 | 682M | +3.0% |
| Q1 FY2026 | Mar 31, 2026 | 670M | +1.1% |
| Q4 FY2025 | Dec 31, 2025 | 663M | -0.0% |
| Q3 FY2025 | Sep 30, 2025 | 663M | 0.0% |
| Q2 FY2025 | Jun 30, 2025 | 663M | +0.7% |
| Q1 FY2025 | Mar 31, 2025 | 663M | +89.0% |
| Q4 FY2024 | Dec 31, 2024 | 663M | +85.3% |
| Q3 FY2024 | Sep 30, 2024 | 663M | +124.5% |
| Q2 FY2024 | Jun 30, 2024 | 658M | +119.6% |
| Q1 FY2024 | Mar 31, 2024 | 351M | +19.7% |
| Q4 FY2023 | Dec 31, 2023 | 358M | +41.4% |
| Q3 FY2023 | Sep 30, 2023 | 295M | +22.4% |
| Q2 FY2023 | Jun 30, 2023 | 300M | +50.0% |
| Q1 FY2023 | Mar 31, 2023 | 293M | +96.3% |
| Q4 FY2022 | Dec 31, 2022 | 253M | +132.2% |
| Q3 FY2022 | Sep 30, 2022 | 241M | +185.6% |
| Q2 FY2022 | Jun 30, 2022 | 200M | +249.1% |
| Q1 FY2022 | Mar 31, 2022 | 149M | +210.6% |
| Q4 FY2021 | Dec 31, 2021 | 109M | +210.9% |
| Q3 FY2021 | Sep 30, 2021 | 84M | +112.5% |
| Q2 FY2021 | Jun 30, 2021 | 57M | +43.1% |
| Q1 FY2021 | Mar 31, 2021 | 48M | +31.7% |
| Q4 FY2020 | Dec 31, 2020 | 35M | -3.6% |
| Q3 FY2020 | Sep 30, 2020 | 40M | +17.1% |
| Q2 FY2020 | Jun 30, 2020 | 40M | +23.8% |
| Q1 FY2020 | Mar 31, 2020 | 36M | +66.0% |
| Q4 FY2019 | Dec 31, 2019 | 36M | +102.4% |
| Q3 FY2019 | Sep 30, 2019 | 34M | +88.9% |
| Q2 FY2019 | Jun 30, 2019 | 32M | +79.9% |
| Q1 FY2019 | Mar 31, 2019 | 22M | +22.4% |
| Q4 FY2018 | Dec 31, 2018 | 18M | +0.1% |
| Q3 FY2018 | Sep 30, 2018 | 18M | 0.0% |
| Q2 FY2018 | Jun 30, 2018 | 18M | 0.0% |
| Q1 FY2018 | Mar 31, 2018 | 18M | +0.0% |
| Q4 FY2017 | Dec 31, 2017 | 18M | -0.0% |
| Q3 FY2017 | Sep 30, 2017 | 18M | – |
| Q2 FY2017 | Jun 30, 2017 | 18M | – |
| Q1 FY2017 | Mar 31, 2017 | 18M | – |
| Q4 FY2016 | Dec 31, 2016 | 18M | – |
See a number that looks wrong?